3.0.0 96 2019-11-15T21:52:26Z 2019-11-15T21:52:26Z Senate S S 2005-01-24 109 ssfi00 Finance Committee Senate Standing Referred to 2005-01-24T22:26:41Z 2006-07-20 Sponsor introductory remarks on measure. (CR S8051) IntroReferral B00100 9 Library of Congress 2006-04-04 Sponsor introductory remarks on measure. (CR S2844-2845) IntroReferral B00100 9 Library of Congress 2005-01-24 ssfi00 Finance Committee Senate Read twice and referred to the Committee on Finance. IntroReferral 2005-01-24 Sponsor introductory remarks on measure. (CR S261-262) IntroReferral B00100 9 Library of Congress 2005-01-24 Introduced in Senate IntroReferral 10000 9 Library of Congress I000024 Sen. Inhofe, James M. [R-OK] Jim Inhofe R OK N Health Child health Commerce Construction costs Department of Health and Human Services Drug industry Economics and Public Finance Families Federal aid to research Government Operations and Politics Income tax Industrial buildings Influenza Investment tax credit Medicaid National Institutes of Health (NIH) Pharmaceutical research Prices Research centers Science, Technology, Communications Social Welfare Taxation Technological innovations Vaccines Health 00 2005-01-24 Introduced in Senate 2005-02-05T16:33:48Z Flu Vaccine Incentive Act of 2005 or FLU-VIA - Rescinds the authority of the Secretary of Health and Human Services under the Consolidated Appropriations Act, 2005, to make certain purchases of inflluenza vaccine.

Amends title XIX (Medicaid) of the Social Security Act to exempt contracts entered into by the Secretary for the purchase of a pediatric influenza vaccine and other vaccines from certain price restrictions otherwise applicable to such contracts. Extends such exemption to any other Federal agency that purchases an influenza vaccine.

Amends the Internal Revenue Code to allow a tax credit for investment in influenza vaccine manufacturing facilities.

]]> Flu Vaccine Incentive Act of 2005 Short Titles as Introduced Flu Vaccine Incentive Act of 2005 Short Titles as Introduced FLU-VIA Display Title Flu Vaccine Incentive Act of 2005 Official Title as Introduced A bill to target Federal funding for research and development, to amend section 1928 of the Social Security Act to encourage the production of influenza vaccines by eliminating the price cap applicable to the purchase of such vaccines under contracts entered into by the Secretary of Health and Human Services, to amend the Internal Revenue Code of 1986 to establish a tax credit to encourage vaccine production capacity, and for other purposes. Introduced in Senate 2005-01-24T05:00:00Z https://www.govinfo.gov/content/pkg/BILLS-109s96is/xml/BILLS-109s96is.xml 2006-07-20 Sponsor introductory remarks on measure. (CR S8051) text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.